Investing.com - Erytech Pharma ADR reported on Thursday third quarter earnings that matched analysts' forecasts and revenue that was inline with expectations.
Erytech Pharma ADR announced earnings per share of $-1.06 on revenue of $2.29M. Analysts polled by Investing.com anticipated EPS of $-1.06 on revenue of $2.29M.
Erytech Pharma ADR shares are down 3.46% from the beginning of the year and are trading at $7.12 , down-from-52-week-high.They are under-performing the Nasdaq which is up 32.52% from the start of the year.
Erytech Pharma ADR follows other major sector earnings this month
Erytech Pharma ADR's report follows an earnings beat by Industrial Commercial Bank of China on Friday, October 30, 2020, who reported EPS of $0.66 on revenue of $29.54B, compared to forecasts EPS of $0.49 on revenue of $28.59B.
China Construction Bank Corp had beat expectations on Thursday, October 29, 2020 with third quarter EPS of $0.81 on revenue of $26.74B, compared to forecast for EPS of $0.75 on revenue of $25.24B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar